Duality Advisers, LP Gilead Sciences, Inc. Transaction History

Duality Advisers, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $5.17 Million - $6.3 Million	72,177 New	72,177 $5.29 Million
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $1.53 Million - $1.72 Million	-26,439 Reduced 77.31%	7,758 $480,000
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $1.98 Million - $2.48 Million	34,197 New	34,197 $2.03 Million
Q4 2020 Feb 09, 2021	SELL	$56.65 - $64.55 $820,292 - $934,684	-14,480 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $263,179 - $330,903	-4,238 Reduced 22.64%	14,480 $915,000
Q2 2020 Jul 29, 2020	BUY	$72.34 - $84.0 $1.35 Million - $1.57 Million	18,718 New	18,718 $1.44 Million
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $4.17 Million - $5.34 Million	-66,528 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $4.1 Million - $4.51 Million	66,528 New	66,528 $4.32 Million
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $8.54 Million - $9.43 Million	-136,670 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $8.46 Million - $9.48 Million	136,670 New	136,670 $9.23 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.